Skip to content
NASDAQ · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Alterity Therapeutics Ltd. ATHE

10 fiscal years on record · AUD · FY2024 reported · SEC filings only
AUD -12.1M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2024 · full 10-year series below
Revenue AUD M Net income AUD M
FY2017 · Revenue 0.2 · Net income -8.3
-3M-6M
2015201820212024
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
ROE

No chart to show — the reason differs by year; see each year in the table below.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot available: we don't have a clean operating profit figure for this period.

Cash & shareholders

·
returned in FY2024 · dividends + net buybacks
Free cash flow AUD M
FY2023 · FCF -12.6
-10M-20M
201520192024

Total assetsAUD 46.0M
EquityAUD -225.9M
CashAUD 33.2M
Current ratio12.98×

Equity funds -491% of total assets.

The 10-year record

10 fiscal years
Every figure from documents filed with the SEC · AUD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
ATHE, 10-year financial record
Metric 2024202320222021202020192018201720162015
Revenue AUD B◌◌◌◌◌◌◌0.00.00.0
Operating income AUD B◌◌◌◌◌◌◌◌◌◌
EBITDA AUD B◌◌◌◌◌◌◌◌◌◌
Income tax AUD B0.00.00.00.0◌◌0.00.00.00.0
Net income AUD B−0.0−0.0−0.0−0.00.00.00.0−0.0−0.0−0.0
Free cash flow AUD B◌−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted AUD −0.19−0.52−0.57−0.53−0.90−1.50−2.00◌◌◌
Dividend / sh AUD ◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend——————————
ROE %———◌◌◌◌◌◌◌
Shares out B◌◌2.442.412.08◌◌◌◌◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 6 failures in 34 reconciliationsAUDITED

Reconciled in 4 of the 10 fiscal years we could check. 18 checks were skipped: the balance sheet is not tagged before 2016. 11 checks were skipped: EPS is not tagged before 2018.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency6 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inoutside the United States — SEC code C3
Fiscal year endsJune 30
Data on record since2015

Share this section

Download image